| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| APGE | Apogee Therapeutics, Inc. | Jane Henderson | Chief Financial Officer | Nov 25, 2025 | Sale | $70.00 | 1,500 | 105,000 | 196,371 | Nov 28, 2025, 08:00 PM | |
| APGE | Apogee Therapeutics, Inc. | Jane Henderson | Chief Financial Officer | Nov 14, 2025 | Sale | $65.00 | 2,000 | 130,000 | 197,871 | Nov 14, 2025, 08:00 PM | |
| APGE | Apogee Therapeutics, Inc. | Jane Henderson | Chief Financial Officer | Nov 11, 2025 | Sale | $60.00 | 1,000 | 60,000 | 199,871 | Nov 13, 2025, 08:37 PM | |
| AKRO | Akero Therapeutics, Inc. | Jane Henderson | Director | Aug 12, 2025 | Sale | $47.46 | 3,000 | 142,371 | 9,398 | Aug 12, 2025, 08:32 PM | |
| AKRO | Akero Therapeutics, Inc. | Jane Henderson | Director | Aug 12, 2025 | Option/RSU Exercise | $7.01 | 3,000 | 21,027 | 12,398 | Aug 12, 2025, 08:32 PM | |
| APGE | Apogee Therapeutics, Inc. | Jane Henderson | Chief Financial Officer | Aug 23, 2024 | Sale | $48.26 | 6,000 | 289,560 | 200,871 | Aug 23, 2024, 08:05 PM | |
| AKRO | Akero Therapeutics, Inc. | Jane Henderson | Director | Jun 16, 2023 | Option/RSU Exercise | $7.01 | 40,000 | 280,400 | 40,000 | Jun 21, 2023, 05:47 PM | |
| AKRO | Akero Therapeutics, Inc. | Jane Henderson | Director | Jun 16, 2023 | Sale | $54.17 | 40,000 | 2,166,685 | 22,498 | Jun 21, 2023, 05:47 PM | |
| VYGR | Voyager Therapeutics, Inc. | Jane Henderson | Sr. V.P. & CFO, Corp. Dev. | Mar 23, 2018 | Sale | $20.52 | 11,200 | 229,824 | 0 | Mar 26, 2018, 04:02 PM | |
| VYGR | Voyager Therapeutics, Inc. | Jane Henderson | Sr. V.P. & CFO, Corp. Dev. | Mar 22, 2018 | Option/RSU Exercise | $11.97 | 19,900 | 238,203 | 19,900 | Mar 26, 2018, 04:02 PM | |
| VYGR | Voyager Therapeutics, Inc. | Jane Henderson | Sr. V.P. & CFO, Corp. Dev. | Mar 22, 2018 | Sale | $21.07 | 19,900 | 419,293 | 0 | Mar 26, 2018, 04:02 PM | |
| VYGR | Voyager Therapeutics, Inc. | Jane Henderson | Sr. V.P. & CFO, Corp. Dev. | Mar 23, 2018 | Option/RSU Exercise | $11.97 | 11,200 | 134,064 | 11,200 | Mar 26, 2018, 04:02 PM | |
| VYGR | Voyager Therapeutics, Inc. | Jane Henderson | CFO & SVP, Corp. Dev. | Mar 19, 2018 | Option/RSU Exercise | $11.97 | 1,900 | 22,743 | 1,900 | Mar 20, 2018, 05:43 PM | |
| VYGR | Voyager Therapeutics, Inc. | Jane Henderson | CFO & SVP, Corp. Dev. | Mar 19, 2018 | Sale | $21.76 | 1,900 | 41,344 | 0 | Mar 20, 2018, 05:43 PM | |
| VYGR | Voyager Therapeutics, Inc. | Jane Henderson | CFO & SVP, Corp. Dev. | Mar 16, 2018 | Option/RSU Exercise | $11.97 | 15,416 | 184,530 | 15,416 | Mar 20, 2018, 05:43 PM | |
| VYGR | Voyager Therapeutics, Inc. | Jane Henderson | CFO & SVP, Corp. Dev. | Mar 16, 2018 | Sale | $22.15 | 15,416 | 341,464 | 0 | Mar 20, 2018, 05:43 PM |